RecruitingNCT01186133
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Sponsor
Seung-Jung Park
Enrollment
50,000 participants
Start Date
Jan 1, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria2
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Exclusion Criteria3
- patients with a mixture of several DES
- terminal illness with life expectancy less than 1 year
- patients with cardiogenic shock
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01186133
Related Trials
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT069547148 locations
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
NCT068211911 location
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
NCT072693661 location
Coronary Artery Disease Assessment Strategies in TAVI Patients
NCT065593321 location
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT058500911 location